Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Multiple luminal toxins and proteins" does not refer to a single molecular target but rather a broad category of substances found within the lumen of the gastrointestinal tract that are targeted by adsorbents and sequestrants. These substances include uremic toxin precursors (such as indole), bacterial endotoxins (like lipopolysaccharide), bile acids, and inflammatory cytokines or proteins. In therapeutic contexts, drugs like AST-120 (Kremezin) or activated charcoal are used to bind these molecules to prevent their systemic absorption or to mitigate local damage in conditions such as chronic kidney disease, hepatic encephalopathy, or acute poisoning. Because this "target" is a heterogeneous collection of molecules rather than a specific protein or receptor, it is considered a descriptive pharmacological target rather than a canonical biological one.
Adsorption or sequestration of various substances within the gastrointestinal lumen to prevent their absorption or local toxic effects.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple luminal toxins and proteins.